| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nephrol Dial Transplant (2000) 15: 218-223
© 2000 European Renal Association-European Dialysis and Transplant Association
Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure
1 Departments of Internal Medicine, Heidelberg, 2 Department of Internal Medicine, Jena, 3 Department of Pathology, Heidelberg, 4 Department of Pathology, Darmstadt and 5 Department of Pathology, Jena, Germany
Correspondence and offprint requests to: Prof. Dr Kerstin Amann, Department of Pathology, University of Erlangen-Nürnberg, Krankenhausstr. 8–10, D-91054 Erlangen, Germany. e-mail: kerstin.amann{at}patho.med.uni-erlangen.de.
Background. An excessive rate of cardiac death is a well-known feature of renal failure. Coronary heart disease is frequent and the possibility has been raised that the natural history of the coronary plaque is different in uraemic patients. We assessed the morphology of coronary arteries in patients with end-stage renal failure and compared them with coronary arteries of matched non-uraemic control patients.
Methods. Fifty-four cases were identified at autopsy who met the inclusion criteria: cases, end-stage renal disease (n=27); controls, non-renal patients with coronary artery disease (n=27). At autopsy all three coronary arteries were prepared at corresponding sites for investigations: (i) qualitative analysis (after Stary), (ii) quantitative measurements of intima and media thickness (by planimetry), (iii) immunohistochemical analysis of the coronary plaques and (iv) X-ray diffraction of selected calcified plaques.
Results. Qualitative analysis of the coronary arteries showed significantly more calcified plaques of coronary arteries in patients with end-stage renal failure. Plaques of non-uraemic patients were mostly fibroatheromatous. Media thickness of coronary arteries was significantly higher in uraemic patients (187±53 µm vs 135±29 µm in controls) and intima thickness tended to be higher (158±38 µm vs 142±31 µm) but this difference was not statistically significant. Plaque area (4.09±1.50 mm2 vs 4.39±0.88 mm2) was comparable in both groups. Lumen area, however, was significantly lower in end-stage renal patients. Immunohistochemical analysis of the cellular infiltrate in coronary arteries showed no major differences in these advanced plaques of uraemic and non-uraemic subjects.
Conclusion. Coronary plaques in patients with end-stage renal failure are characterized by increased media thickness and marked calcification. In contrast to the previous opinion the most marked difference compared to non-uraemic controls does not concern the size, but the composition of the plaque. Deposition of calcium within the plaques may contribute to the high complication rate in uraemic patients.
Keywords: atherosclerosis; uraemia; coronary artery disease; plaque structure; calcification
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Caliskan, M. Demirturk, A. Ozkok, B. Yelken, T. Sakaci, H. Oflaz, A. Unsal, and A. Yildiz Coronary artery calcification and coronary flow velocity in haemodialysis patients Nephrol. Dial. Transplant., February 26, 2010; (2010) gfq113v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, M. Y. Speer, H. Yang, J. Bergen, and C. M. Giachelli Vitamin D Receptor Activators Induce an Anticalcific Paracrine Program in Macrophages: Requirement of Osteopontin Arterioscler Thromb Vasc Biol, February 1, 2010; 30(2): 321 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Sniderman, A. Solhpour, A. Alam, K. Williams, and J. A. Sloand Cardiovascular Death in Dialysis Patients: Lessons We Can Learn from AURORA Clin. J. Am. Soc. Nephrol., February 1, 2010; 5(2): 335 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Ford, L. A. Tomlinson, E. R. Smith, C. Rajkumar, and S. G. Holt Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4 Nephrol. Dial. Transplant., January 14, 2010; (2010) gfp723v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Wade and M. P. Reilly Coronary Calcification in Chronic Kidney Disease: Morphology, Mechanisms and Mortality Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(12): 1883 - 1885. [Full Text] [PDF]
|
|
|
|
|
|
I. Bhan and R. Thadhani Vascular Calcification and ESRD: A Hard Target Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(Supplement_1): S102 - S105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mehran, E. Nikolsky, A. J. Lansky, A. J. Kirtane, Y.-H. Kim, F. Feit, S. Manoukian, J. W. Moses, R. Ebrahimi, E. M. Ohman, et al. Impact of Chronic Kidney Disease on Early (30-Day) and Late (1-Year) Outcomes of Patients With Acute Coronary Syndromes Treated With Alternative Antithrombotic Treatment Strategies: An ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Substudy J. Am. Coll. Cardiol. Intv., August 1, 2009; 2(8): 748 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Aikawa, M. Aikawa, P. Libby, J.-L. Figueiredo, G. Rusanescu, Y. Iwamoto, D. Fukuda, R. H. Kohler, G.-P. Shi, F. A. Jaffer, et al. Arterial and Aortic Valve Calcification Abolished by Elastolytic Cathepsin S Deficiency in Chronic Renal Disease Circulation, April 7, 2009; 119(13): 1785 - 1794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Matias, C. Ferreira, C. Jorge, M. Borges, I. Aires, T. Amaral, C. Gil, J. Cortez, and A. Ferreira 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients Nephrol. Dial. Transplant., February 1, 2009; 24(2): 611 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Porazko, J. Kuzniar, M. Kusztal, T. J. Kuzniar, W. Weyde, M. Kuriata-Kordek, and M. Klinger IL-18 is involved in vascular injury in end-stage renal disease patients Nephrol. Dial. Transplant., February 1, 2009; 24(2): 589 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Rashid, E. Plotkin, O. Klein, J. Green, J. Bernheim, and S. Benchetrit Parathyroid hormone decreases endothelial osteoprotegerin secretion: role of protein kinase A and C Am J Physiol Renal Physiol, January 1, 2009; 296(1): F60 - F66. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. McCullough, V. Agrawal, E. Danielewicz, and G. S. Abela Accelerated Atherosclerotic Calcification and Monckeberg's Sclerosis: A Continuum of Advanced Vascular Pathology in Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1585 - 1598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Amann Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1599 - 1605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ritz and C. Wanner Lipid Abnormalities and Cardiovascular Risk in Renal Disease J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1065 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Raggi and M. Kleerekoper Contribution of Bone and Mineral Abnormalities to Cardiovascular Disease in Patients with Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 836 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Stenvinkel, J. J. Carrero, J. Axelsson, B. Lindholm, O. Heimburger, and Z. Massy Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient: How Do New Pieces Fit into the Uremic Puzzle? Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 505 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Toussaint, K. K. Lau, B. J. Strauss, K. R. Polkinghorne, and P. G. Kerr Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease Nephrol. Dial. Transplant., February 1, 2008; 23(2): 586 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Porter, A. Stavroulopoulos, S. D. Roe, K. Pointon, and M. J.D. Cassidy Detection of coronary and peripheral artery calcification in patients with chronic kidney disease stages 3 and 4, with and without diabetes Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3208 - 3213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Wu-Wong, M. Nakane, J. Ma, X. Ruan, and P. E. Kroeger Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1592 - F1604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Nogueira and M. Weir The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 766 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Raggi, A. Bellasi, E. Ferramosca, G. A. Block, and P. Muntner Pulse Wave Velocity Is Inversely Related to Vertebral Bone Density in Hemodialysis Patients Hypertension, June 1, 2007; 49(6): 1278 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Hocher, L. Liefeldt, T. Quaschning, P. Kalk, R. Ziebig, M. Godes, K. Relle, G. Asmus, and J.-P. Stasch Soluble CD154 Is a Unique Predictor of Nonfatal and Fatal Atherothrombotic Events in Patients Who Have End-Stage Renal Disease and Are on Hemodialysis J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1323 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-L. Gross, H.-P. Meyer, H. Ziebart, P. Rieger, U. Wenzel, K. Amann, I. Berger, M. Adamczak, P. Schirmacher, and E. Ritz Calcification of Coronary Intima and Media: Immunohistochemistry, Backscatter Imaging, and X-Ray Analysis in Renal and Nonrenal Patients Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 121 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Nikolov, N. Joki, T. Drueke, and Z. Massy Beyond phosphate--role of uraemic toxins in cardiovascular calcification Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3354 - 3357. [Full Text] [PDF]
|
|
|
|
 |
|
 N.C. Edwards, R.P. Steeds, C.J. Ferro, and J.N. Townend The treatment of coronary artery disease in patients with chronic kidney disease QJM, November 1, 2006; 99(11): 723 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Coca, H. M. Krumholz, A. X. Garg, and C. R. Parikh Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA, September 20, 2006; 296(11): 1377 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Persy, A. Postnov, E. Neven, G. Dams, M. De Broe, P. D'Haese, and N. De Clerck High-Resolution X-Ray Microtomography Is a Sensitive Method to Detect Vascular Calcification in Living Rats With Chronic Renal Failure Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2110 - 2116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Ix, G. M. Chertow, M. G. Shlipak, V. M. Brandenburg, M. Ketteler, and M. A. Whooley Fetuin-A and kidney function in persons with coronary artery disease--data from the heart and soul study Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2144 - 2151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tonelli, F. Sacks, M. Pfeffer, Z.H. Gao, G. Curhan, for the Cholesterol and Recurrent Events (CARE) Tr, P. Rossing, K. Rossing, P. Gaede, O. Pedersen, et al. Serum Phosphate: A Novel Cardiovascular Risk Factor Even in Nonrenal Patients: Relation between Serum Phosphate Level and Cardiovascular Event Rate in People with Coronary Disease. Circulation 112: 2627-2633, 2005 J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2077 - 2085. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Wu-Wong, W. Noonan, J. Ma, D. Dixon, M. Nakane, A. L. Bolin, K. A. Koch, S. Postl, S. J. Morgan, and G. A. Reinhart Role of Phosphorus and Vitamin D Analogs in the Pathogenesis of Vascular Calcification J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 90 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Merx, C. Schafer, R. Westenfeld, V. Brandenburg, S. Hidajat, C. Weber, M. Ketteler, and W. Jahnen-Dechent Myocardial Stiffness, Cardiac Remodeling, and Diastolic Dysfunction in Calcification-Prone Fetuin-A-Deficient Mice J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3357 - 3364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Phan, O. Ivanovski, T. Nguyen-Khoa, N. Mothu, J. Angulo, R. Westenfeld, M. Ketteler, N. Meert, J. Maizel, I. G. Nikolov, et al. Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E-Deficient Mice Circulation, November 1, 2005; 112(18): 2875 - 2882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Nolan Strategies for Improving Long-Term Survival in Patients with ESRD J. Am. Soc. Nephrol., November 1, 2005; 16(11_suppl_2): S120 - S127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Qiao, T. M. Doherty, M. C. Fishbein, I. B. Salusky, D. L. Luthringer, L. A. Fitzpatrick, P. K. Shah, and T. B. Rajavashisth Calcification of the Coronary Arteries in the Absence of Atherosclerotic Plaque Mayo Clin. Proc., June 1, 2005; 80(6): 807 - 809. [Abstract] [PDF]
|
|
|
|
|
|
M. Litwin, E. Wuhl, C. Jourdan, J. Trelewicz, A. Niemirska, K. Fahr, K. Jobs, R. Grenda, Z. T. Wawer, P. Rajszys, et al. Altered Morphologic Properties of Large Arteries in Children with Chronic Renal Failure and after Renal Transplantation J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1494 - 1500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Giachelli, M. Y. Speer, X. Li, R. M. Rajachar, and H. Yang Regulation of Vascular Calcification: Roles of Phosphate and Osteopontin Circ. Res., April 15, 2005; 96(7): 717 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yildiz, E. Memisoglu, H. Oflaz, H. Yazici, H. Pusuroglu, V. Akkaya, F. Erzengin, and S. Tepe Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients Nephrol. Dial. Transplant., April 1, 2005; 20(4): 760 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y.-M. Wang, S. S.-Y. Ho, M. Wang, E. K.-H. Liu, S. Ho, P. K.-T. Li, S.-F. Lui, and J. E. Sanderson Cardiac Valvular Calcification as a Marker of Atherosclerosis and Arterial Calcification in End-stage Renal Disease Arch Intern Med, February 14, 2005; 165(3): 327 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Bongartz, M. J. Cramer, P. A. Doevendans, J. A. Joles, and B. Braam The severe cardiorenal syndrome: 'Guyton revisited' Eur. Heart J., January 1, 2005; 26(1): 11 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. A. Massy, O. Ivanovski, T. Nguyen-Khoa, J. Angulo, D. Szumilak, N. Mothu, O. Phan, M. Daudon, B. Lacour, T. B. Drueke, et al. Uremia Accelerates both Atherosclerosis and Arterial Calcification in Apolipoprotein E Knockout Mice J. Am. Soc. Nephrol., January 1, 2005; 16(1): 109 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Giachelli Vascular Calcification Mechanisms J. Am. Soc. Nephrol., December 1, 2004; 15(12): 2959 - 2964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S Joy, A. V Kshirsagar, and N. Franceschini Calcimimetics and the Treatment of Primary and Secondary Hyperparathyroidism Ann. Pharmacother., November 1, 2004; 38(11): 1871 - 1880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gupta, Y. Birnbaum, and B. F. Uretsky The renal patient with coronary artery disease: Current concepts and dilemmas J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1343 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Moe and N. X. Chen Pathophysiology of Vascular Calcification in Chronic Kidney Disease Circ. Res., September 17, 2004; 95(6): 560 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bro, F. Moeller, C. B. Andersen, K. Olgaard, and L. B. Nielsen Increased Expression of Adhesion Molecules in Uremic Atherosclerosis in Apolipoprotein-E-Deficient Mice J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1495 - 1503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yildiz, S. Tepe, H. Oflaz, H. Yazici, H. Pusuroglu, M. Besler, E. Ark, and F. Erzengin Carotid atherosclerosis is a predictor of coronary calcification in chronic haemodialysis patients Nephrol. Dial. Transplant., April 1, 2004; 19(4): 885 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension, November 1, 2003; 42(5): 1050 - 1065. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation, October 28, 2003; 108(17): 2154 - 2169. [Full Text] [PDF]
|
|
|
|
|
|
S. Bro, J. F. Bentzon, E. Falk, C. B. Andersen, K. Olgaard, and L. B. Nielsen Chronic Renal Failure Accelerates Atherogenesis in Apolipoprotein E-Deficient Mice J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2466 - 2474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Herzog How to Manage the Renal Patient with Coronary Heart Disease: The Agony and the Ecstasy of Opinion-Based Medicine J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2556 - 2572. [Full Text] [PDF]
|
|
|
|
|
|
P. Stenvinkel, R. Pecoits-Filho, and B. Lindholm Coronary Artery Disease in End-Stage Renal Disease: No Longer a Simple Plumbing Problem J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1927 - 1939. [Full Text] [PDF]
|
|
|
|
|
|
K. Amann, C. Ritz, M. Adamczak, and E. Ritz Why is coronary heart disease of uraemic patients so frequent and so devastating? Nephrol. Dial. Transplant., April 1, 2003; 18(4): 631 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Buzello, J. Tornig, J. Faulhaber, H. Ehmke, E. Ritz, and K. Amann The Apolipoprotein E Knockout Mouse: A Model Documenting Accelerated Atherogenesis In Uremia J. Am. Soc. Nephrol., February 1, 2003; 14(2): 311 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cozzolino, A. S. Dusso, H. Liapis, J. Finch, Y. Lu, S. K. Burke, and E. Slatopolsky The Effects of Sevelamer Hydrochloride and Calcium Carbonate on Kidney Calcification in Uremic Rats J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2299 - 2308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. B. Drueke and S. G. Rostand Progression of vascular calcification in uraemic patients: can it be stopped? Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1365 - 1368. [Full Text] [PDF]
|
|
|
|
|
|
J. Oh, R. Wunsch, M. Turzer, M. Bahner, P. Raggi, U. Querfeld, O. Mehls, and F. Schaefer Advanced Coronary and Carotid Arteriopathy in Young Adults With Childhood-Onset Chronic Renal Failure Circulation, July 2, 2002; 106(1): 100 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Coladonato, L. A. Szczech, E. A. Friedman, and W. F. Owen Jr Does calcium kill ESRD patients--the skeptic's perspective Nephrol. Dial. Transplant., February 1, 2002; 17(2): 229 - 232. [Full Text] [PDF]
|
|
|
|
|
|
P. Raggi Effects of excess calcium load on the cardiovascular system measured with electron beam tomography in end-stage renal disease Nephrol. Dial. Transplant., February 1, 2002; 17(2): 332 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Herzog Dismal long-term survival of dialysis patients after acute myocardial infarction: can we alter the outcome? Nephrol. Dial. Transplant., January 1, 2002; 17(1): 7 - 10. [Full Text] [PDF]
|
|
|
|
|
|
H. Hase, M. Nakamura, N. Joki, T. Tsunoda, R. Nakamura, T. Saijyo, M. Morishita, and T. Yamaguchi Independent predictors of restenosis after percutaneous coronary revascularization in haemodialysis patients Nephrol. Dial. Transplant., December 1, 2001; 16(12): 2372 - 2377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. COZZOLINO, A. S. DUSSO, and E. SLATOPOLSKY Role of Calcium-Phosphate Product and Bone-Associated Proteins on Vascular Calcification in Renal Failure J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2511 - 2516. [Full Text] [PDF]
|
|
|
|
 |
|
 A. G Jardine and K. McLaughlin GENERAL CARDIOLOGY: Cardiovascular complications of renal disease Heart, October 1, 2001; 86(4): 459 - 466. [Full Text] [PDF]
|
|
|
|
|
|
K. AMANN, G. MIL TENBERGER-MIL TENYI, A. SIMONOVICIENE, A. KOCH, S. ORTH, and E. RITZ Remodeling of Resistance Arteries in Renal Failure: Effect of Endothelin Receptor Blockade J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2040 - 2050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. GANESH, A. G. STACK, N. W. LEVIN, T. HULBERT-SHEARON, and F. K. PORT Association of Elevated Serum PO4, Ca PO4 Product, and Parathyroid Hormone with Cardiac Mortality Risk in Chronic Hemodialysis Patients J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2131 - 2138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Elsner How to diagnose and treat coronary artery disease in the uraemic patient: an update Nephrol. Dial. Transplant., June 1, 2001; 16(6): 1103 - 1108. [Full Text] [PDF]
|
|
|
|
|
|
I. B. Salusky and W. G. Goodman Managing phosphate retention: is a change necessary? Nephrol. Dial. Transplant., November 1, 2000; 15(11): 1738 - 1742. [Full Text] [PDF]
|
|
|
|
|
|
K. Amann and E. Ritz Microvascular disease--the Cinderella of uraemic heart disease Nephrol. Dial. Transplant., October 1, 2000; 15(10): 1493 - 1503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Farzaneh-Far and K. Amann Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure Nephrol. Dial. Transplant., October 1, 2000; 15(10): 1710 - 1710. [Full Text] [PDF]
|
|
|
|
|
|
S. G. ROSTAND Coronary Heart Disease in Chronic Renal Insufficiency: Some Management Considerations J. Am. Soc. Nephrol., October 1, 2000; 11(10): 1948 - 1956. [Full Text]
|
|